NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00015951 2019-10-17Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic CancersUniversity of Maryland, BaltimorePhase 2 Completed